Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Both approaches may offer a nonpharmaceutical option to use instead of or alongside opioids pain medication.
Tumor-treating fields therapy uses electricity delivered via a wearable device to kill cancer cells.
Responders may be able to discontinue immune checkpoint inhibitors after two years with no decrease in survival.
Food insecurity and worry about paying for housing and other necessities were associated with higher mortality.
The targeted therapy delayed disease progression in patients with the most common type of early-stage breast cancer.
A one percentage point increase in the population with medical debt was associated with an increase in mortality for all malignancies.
The daily medication led to improvements in libido, sexual function and overall quality of life.
Black cancer survivors also have a higher risk of death from heart disease, new study shows.
The oral targeted therapy led to a 51% improvement in survival for patients with EGFR-mutated non-small-cell lung cancer.
Study authors recommend programs to screen for loneliness among cancer survivors and to provide social support to those in need.
Keytruda plus chemotherapy reduced the risk of death by about 40% for people with persistent, recurrent or metastatic cervical cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.